Human Genetics Society of Australasia Position Statement: Genetic Carrier Testing for Recessive Conditions.

IF 1 4区 医学 Q4 GENETICS & HEREDITY
Danya F Vears, Jackie Boyle, Chris Jacobs, Aideen McInerney-Leo, Ainsley J Newson
{"title":"Human Genetics Society of Australasia Position Statement: Genetic Carrier Testing for Recessive Conditions.","authors":"Danya F Vears,&nbsp;Jackie Boyle,&nbsp;Chris Jacobs,&nbsp;Aideen McInerney-Leo,&nbsp;Ainsley J Newson","doi":"10.1017/thg.2023.15","DOIUrl":null,"url":null,"abstract":"<p><p>This Position Statement provides guidelines to assist all health professionals who receive requests for carrier testing and laboratory staff conducting the tests.In this Statement, the term 'carrier testing' refers to genetic testing in an individual to determine whether they have inherited a pathogenic variant associated with an autosomal or X-linked recessive condition previously identified in a blood relative. Carrier testing recommendations: (1) Carrier testing should only be performed with the individual's knowledge and consent; (2) An individual considering (for themselves, or on behalf of another) whether to have a carrier test should be supported to make an informed decision; (3) The mode of inheritance, the individual's personal experience with the condition, and the healthcare setting in which the test is being performed should be considered when determining whether carrier testing should be offered by a genetic health professional. Regarding children and young people: Unless there is direct medical benefit in the immediate future, the default position should be to postpone carrier testing until the child or young person can be supported to make an informed decision. There may be some specific situations where it is appropriate to facilitate carrier testing in children and young people (see section in this article). In such cases, testing should only be offered with pre- and post-test genetic counseling in which genetic health professionals and parents/guardians should explore the rationale for testing and the interests of the child and the family.</p>","PeriodicalId":23446,"journal":{"name":"Twin Research and Human Genetics","volume":"26 2","pages":"188-194"},"PeriodicalIF":1.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Twin Research and Human Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/thg.2023.15","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 1

Abstract

This Position Statement provides guidelines to assist all health professionals who receive requests for carrier testing and laboratory staff conducting the tests.In this Statement, the term 'carrier testing' refers to genetic testing in an individual to determine whether they have inherited a pathogenic variant associated with an autosomal or X-linked recessive condition previously identified in a blood relative. Carrier testing recommendations: (1) Carrier testing should only be performed with the individual's knowledge and consent; (2) An individual considering (for themselves, or on behalf of another) whether to have a carrier test should be supported to make an informed decision; (3) The mode of inheritance, the individual's personal experience with the condition, and the healthcare setting in which the test is being performed should be considered when determining whether carrier testing should be offered by a genetic health professional. Regarding children and young people: Unless there is direct medical benefit in the immediate future, the default position should be to postpone carrier testing until the child or young person can be supported to make an informed decision. There may be some specific situations where it is appropriate to facilitate carrier testing in children and young people (see section in this article). In such cases, testing should only be offered with pre- and post-test genetic counseling in which genetic health professionals and parents/guardians should explore the rationale for testing and the interests of the child and the family.

澳大利亚人类遗传学会立场声明:隐性条件的遗传载体检测。
本立场声明提供指导方针,以协助所有接受带菌者检测请求的卫生专业人员和进行检测的实验室工作人员。在本声明中,术语“携带者检测”是指对个体进行基因检测,以确定他们是否遗传了与常染色体或x连锁隐性遗传病相关的致病性变异,该遗传病先前在血亲中发现。载体测试建议:(1)载体测试应在个人知情和同意的情况下进行;(2)应支持考虑(为自己或代表他人)是否进行携带者测试的个人做出明智的决定;(3)在决定是否应由遗传健康专业人员提供携带者检测时,应考虑遗传模式、个体对该疾病的个人经历以及进行检测的医疗保健环境。关于儿童和年轻人:除非在不久的将来有直接的医疗效益,默认的立场应该是推迟携带者检测,直到儿童或年轻人能够得到支持做出明智的决定。在某些特定情况下,促进儿童和年轻人的携带者检测可能是合适的(见本文部分)。在这种情况下,只能提供检测前和检测后的遗传咨询,遗传健康专业人员和父母/监护人应探讨检测的理由以及儿童和家庭的利益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Twin Research and Human Genetics
Twin Research and Human Genetics 医学-妇产科学
CiteScore
1.50
自引率
11.10%
发文量
37
审稿时长
6-12 weeks
期刊介绍: Twin Research and Human Genetics is the official journal of the International Society for Twin Studies. Twin Research and Human Genetics covers all areas of human genetics with an emphasis on twin studies, genetic epidemiology, psychiatric and behavioral genetics, and research on multiple births in the fields of epidemiology, genetics, endocrinology, fetal pathology, obstetrics and pediatrics. Through Twin Research and Human Genetics the society aims to publish the latest research developments in twin studies throughout the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信